DeepQure Appoints Jason G. Jones to Lead Clinical and Regulatory Affairs DeepQure has announced Jason G. Jones as their new Global VP of Clinical Regulatory Affairs, enhancing leadership in hypertension solutions.

DeepQure Appoints Jason G. Jones to Lead Clinical and Regulatory Affairs #South_Korea #Seoul #DeepQure #HyperQure #Jason_Jones

DeepQure's HyperQure™ Receives Approval for AF Clinical Trials in South Korea DeepQure's innovative HyperQure™ system has secured approval for clinical trials in South Korea to treat atrial fibrillation. This marks a significant step in cardiovascular technology.

DeepQure's HyperQure™ Receives Approval for AF Clinical Trials in South Korea #South_Korea #Seoul #Atrial_Fibrillation #DeepQure #HyperQure

DeepQure Revolutionizes Hypertension Treatment with Innovative Technology in Global Trials DeepQure Inc. is transforming resistant hypertension therapy with its groundbreaking RDN technology, paving the way for advanced treatments worldwide.

DeepQure Revolutionizes Hypertension Treatment with Innovative Technology in Global Trials #South_Korea #Seoul #Hypertension #DeepQure #RDN_Technology